3
Announcements
Trials
Browse
Landscape
Status
Completed
4
Withdrawn
1
Terminated
1
Recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Classical hematology
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myeloid, Acute
3
Leukemia, Biphenotypic, Acute
3
Lymphoma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Anemia, Refractory, with Excess of Blasts
2
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, T-Cell, Cutaneous
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid
1
Leukemia, Monocytic, Acute
1
Leukemia, Mast-Cell
1
Leukemia, Lymphoid
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Hematologic Diseases
1
GATA2 Deficiency
1
Burkitt Lymphoma
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Anemia, Sickle Cell
1
Anemia, Aplastic
1
Interventions
venetoclax
30
obinutuzumab
22
acalabrutinib
20
Specimen Handling
19
ibrutinib
16
Cyclophosphamide
15
Biopsy
15
pirtobrutinib
14
zanubrutinib
12
fludarabine
12
Rituximab
12
Magnetic Resonance Spectroscopy
10
Bendamustine Hydrochloride
5
Stem Cell Transplantation
4
Blood Component Removal
4
ARQ531
4
idelalisib
3
fludarabine phosphate
3
Whole-Body Irradiation
3
Mycophenolic Acid
3
tocilizumab
2
polatuzumab vedotin
2
Watchful Waiting
2
Sirolimus
2
Prednisone
2
Pneumococcal Vaccines
2
Lisaftoclax
2
Leukapheresis
2
Hematopoietic Stem Cell Transplantation
2
Granulocyte Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Leukemia, Lymphocytic, Chronic, B-Cell
×
Bone Marrow Transplantation
×
Clear all
NCT07145411
2025-08-28
HOPE
Ossium Health, Inc.
Recruiting
10 enrolled